Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
Labelled Bilastine. It is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
Van Cauwenberge, P., et al.: Clin. Exp. Allergy, 30, 891